Question 3: What Causes ASD, and Can Disabling Aspects of ASD be Prevented or Preempted?

Funding Country	Funder	Project Title	Funding	Funding	Institution
Funding Country United States	Funder Simons Foundation	Project Title 16p11.2: Defining the gene(s) responsible (grant 1)	$106,050	Funding 106050	Institution Cold Spring Harbor Laboratory
Funding Country United States	Funder Autism Speaks	Project Title Concluding Follow-up of Families Enrolled in the EARLI Cohort	$465,098	Funding 465098	Institution Drexel University
Funding Country United States	Funder National Institutes of Health	Project Title An ASD Enriched Risk (ASD-ER) ECHO Cohort	$1,340,008	Funding 1340008	Institution Drexel University
Funding Country United States	Funder National Institutes of Health	Project Title Prenatal Antimicrobial Agent Exposure, Fetal Androgens and ASD Risk	$156,500	Funding 156500	Institution Drexel University
Funding Country United States	Funder Simons Foundation	Project Title New York Genome Center, Inc.	$9,824,025	Funding 9824025	Institution New York Genome Center, Inc.
Funding Country United States	Funder Simons Foundation	Project Title Baylor College of Medicine (TRADE)	$1,183,000	Funding 1183000	Institution Baylor College of Medicine
Funding Country United States	Funder Simons Foundation	Project Title DNA Genotek Inc.	$930,480	Funding 930480	Institution DNA Genotek Inc.
Funding Country United States	Funder Simons Foundation	Project Title PatientCrossroads, Inc.	$96,812	Funding 96812	Institution PatientCrossroads, Inc.
Funding Country United States	Funder Simons Foundation	Project Title PreventionGenetics LLC	$438,012	Funding 438012	Institution PreventionGenetics LLC
Funding Country United States	Funder Simons Foundation	Project Title Regeneron Pharmaceuticals, Inc.	$259,250	Funding 259250	Institution Regeneron Pharmaceuticals, Inc.